Blomqvist C - Search Results

1

NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer.

Fagerholm R, Hofstetter B, Tommiska J, Aaltonen K, Vrtel R, Syrjäkoski K, Kallioniemi A, Kilpivaara O, Mannermaa A, Kosma VM, Uusitupa M, Eskelinen M, Kataja V, Aittomäki K, von Smitten K, Heikkilä P, Lukas J, Holli K, Bartkova J, Blomqvist C, Bartek J, Nevanlinna H. Fagerholm R, et al. Among authors: blomqvist c. Nat Genet. 2008 Jul;40(7):844-53. doi: 10.1038/ng.155. Epub 2008 May 30. Nat Genet. 2008. PMID: 18511948

2

Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis.

Jahkola T, Toivonen T, von Smitten K, Blomqvist C, Virtanen I. Jahkola T, et al. Among authors: blomqvist c. Int J Cancer. 1996 Dec 20;69(6):445-7. doi: 10.1002/(SICI)1097-0215(19961220)69:6<445::AID-IJC4>3.0.CO;2-4. Int J Cancer. 1996. PMID: 8980244 Free article.

3

Predictive factors for response to cytotoxic treatment in advanced breast cancer: a review.

Sjöström J, Blomqvist C. Sjöström J, et al. Among authors: blomqvist c. Acta Oncol. 1996;35 Suppl 5:84-90. doi: 10.3109/02841869609083978. Acta Oncol. 1996. PMID: 9142975 Review. No abstract available.

4

Long-term prognostic impact of immunohistochemical estrogen receptor determinations compared with biochemical receptor determination in primary breast cancer.

Blomqvist C, von Boguslawski K, Stenman UH, Mäenpää H, von Smitten K, Nordling S. Blomqvist C, et al. Acta Oncol. 1997;36(5):530-2. doi: 10.3109/02841869709001310. Acta Oncol. 1997. PMID: 9292751 No abstract available.

5

Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.

Niskanen E, Blomqvist C, Franssila K, Hietanen P, Wasenius VM. Niskanen E, et al. Among authors: blomqvist c. Br J Cancer. 1997;76(7):917-22. doi: 10.1038/bjc.1997.484. Br J Cancer. 1997. PMID: 9328152 Free PMC article.

6

Breast cancer risk estimation in families with history of breast cancer.

Muhonen T, Eerola H, Vehmanen P, Nevanlinna H, Aktan K, Blomqvist C, Kääriäinen H, Pyrhönen S. Muhonen T, et al. Among authors: blomqvist c. Br J Cancer. 1997;76(9):1228-31. doi: 10.1038/bjc.1997.538. Br J Cancer. 1997. PMID: 9365174 Free PMC article.

7

Tasmuth T, Kataja M, Blomqvist C, von Smitten K, Kalso E. Tasmuth T, et al. Among authors: blomqvist c. Acta Oncol. 1997;36(6):625-30. doi: 10.3109/02841869709001326. Acta Oncol. 1997. PMID: 9408154 Clinical Trial.

8

Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.

Jahkola T, Toivonen T, Virtanen I, von Smitten K, Nordling S, von Boguslawski K, Haglund C, Nevanlinna H, Blomqvist C. Jahkola T, et al. Among authors: blomqvist c. Br J Cancer. 1998 Dec;78(11):1507-13. doi: 10.1038/bjc.1998.714. Br J Cancer. 1998. PMID: 9836485 Free PMC article.

9

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors.

Jahkola T, Toivonen T, von Smitten K, Virtanen I, Wasenius VM, Blomqvist C. Jahkola T, et al. Among authors: blomqvist c. Br J Cancer. 1999 Apr;80(1-2):167-74. doi: 10.1038/sj.bjc.6690336. Br J Cancer. 1999. PMID: 10389993 Free PMC article.

10

Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed?

Helintö M, Blomqvist C, Heikkilä P, Joensuu H. Helintö M, et al. Among authors: blomqvist c. Radiother Oncol. 1999 Sep;52(3):213-7. doi: 10.1016/s0167-8140(99)00099-7. Radiother Oncol. 1999. PMID: 10580866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

634 results

Search Page